MENLO PARK, Calif. — PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, and the UCLA Institute for Precision Health and David Geffen School of Medicine at UCLA have formed a research collaboration to further identify the causes of rare diseases. The study will leverage PacBio’s HiFi long-read sequencing technology for whole genome sequencing (WGS) to look […]
– Represents First Industry Standard Control for Cancer Testing – SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of synthetic DNA using its silicon platform, today announced the launch of the Twist cfDNA Pan-cancer Reference Standards, a high-quality standardized control for use in the development and […]
The 2-year deal with Gene Therapies, Biosimilars, and Monoclonal Antibodies Pharmaceutical Equipment Technology will see nearly 100 of CYTENA’s latest portfolio of cell isolators including the UP.SIGHT be distributed to the massive Chinese life science market Today CYTENA, a BICO company, announced it has signed a 2-year deal with Applitech Pharmaceutical Equipment Technology to distribute […]
GHENT, BELGIUM — Trince, a spin-off of Ghent University (UGent), is developing innovative and efficient technology to insert genetic material into cells. This genetic modification of cells is essential in, for example, cell therapy – an anti-cancer treatment that has become an integral part of modern medicine. Trince has raised EUR 4 million from Novalis […]
Plans for Near-Term Commercialization of its Proteomics and Multi-Omics System BOSTON — NanoMosaic Inc., a Tiger Gene founded company that has established itself as the pioneer and leader in nanoneedle (MosaicNeedle™) detection for proteomics and multi-omics applications, announced today that it has closed an oversubscribed $40,750,000 Series A round of financing led by RA Capital […]
Beijing, China – Sino Biological Inc. (https://www.sinobiological.com; SHE: 301047) announced today that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-CoV-2 virus, which quickly raised concerns around the world because of the high number of mutations it carries, especially the 30-plus mutations on the Spike protein. Sino Biological’s new […]
HELSINKI, Finland — Euformatics, Finnish bioinformatics software company, has today announced that its genomic variant interpretation and reporting tool, omnomicsNGS, has been granted the CE-IVD mark under the In-Vitro Diagnostics Directive (98/79/EC). The software, previously a CE-marked medical device class I under preceding EU legislation, is now making strong progress on its journey to being […]
BOULDER, Colo. — SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that Steve Mermelstein joined the company as Senior Vice President of Corporate Strategy, Development and Mergers and Acquisitions (M&A). “We are thrilled to welcome Steve to the SomaLogic team,” said SomaLogic Chief Executive Officer Roy Smythe, M.D. “His extensive advisory and […]
SARS-CoV-2 Testing including Identification of Omicron Variant December 02, 2021 Eurofins Technologies announces the launch of the VIRSeek SARS-CoV-2 Mplex I and Mplex II Wastewater real-time RT-PCR kits to provide an efficient solution for SARS-CoV-2 detection in wastewater, including the Omicron variant of concern. Wastewater-based epidemiology has become an important approach in order to comprehensively monitor the profile […]
CINCINNATI — Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that Bryan Baldasare, Executive Vice President, Chief Financial Officer, and Secretary, will retire from Meridian effective December 31, 2021. The Company is engaging an executive search firm in the recruitment of a new […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
